Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,683.33p
   
  • Change Today:
    -16.67p
  • 52 Week High: 3,020.00
  • 52 Week Low: 1,366.67
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 9,365
  • Market Cap: £87.95m

Latest Deals

Traded Action Notifier PriceAmountValue
27-Apr-26 Buy Bruce Hiscock 1,679.00p 66 £1,108.14

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
27-Apr-26 Buy Bruce Hiscock 1,679.00p 66 £1,108.14

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 306,172 £5,153,895
Ian James Nicholson 14,500 £244,083
Bruce Hiscock 1,666 £28,044

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £87,864,209
Castlefield Fund Partners Limited 985,000 £16,580,833
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £14,897,500
Gresham House Asset Management Limited 627,782 £10,567,664
Miton Group plc 508,135 £8,553,606
The Diverse Income Trust plc 302,300 £5,088,717
Schroders plc 284,795 £4,794,049
Wasatch Advisors, Inc. 265,000 £4,460,833
Raymond James Wealth Management Limited 263,770 £4,440,128
Premier Miton Group plc 262,812 £4,424,002
Canaccord Genuity Group Inc 259,940 £4,375,657
SANFORD DELAND ASSET MANAGEMENT LTD 254,000 £4,275,667
Adrian Williams 253,372 £4,265,095

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 1,683.33p
Change Today -16.67p
% Change -0.98 %
52 Week High 3,020.00
52 Week Low 1,366.67
Volume 9,365
Shares Issued 5.22m
Market Cap £87.95m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  Interim 2nd Interim
Ex-Div 09-Apr-26 06-Nov-25
Paid 24-Apr-26 21-Nov-25
Amount 70.00p 80.00p

Trades for 14-May-2026

Time Volume / Share Price
11:19 500 @ 1,677.00p
09:53 3,500 @ 1,650.00p
09:50 2,500 @ 1,672.00p
10:41 55 @ 1,677.00p
10:11 250 @ 1,680.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page